<DOC>
	<DOCNO>NCT02796820</DOCNO>
	<brief_summary>A randomize , parallel control clinical study investigate Huaier Granule prevention recurrence metastasis colorectal cancer radical surgery , evaluate efficacy safety .</brief_summary>
	<brief_title>Huaier Granule As Adjuvant Therapy Colorectal Cancer After Radical Surgery</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>The subject volunteer sign informed consent ; Aged : 18 75 year old ; Colorectal cancer ( AJCCTNM , Stage Ⅰ , lowrisk Stage Ⅱand Stage Ⅲ ; Patients Stage Ⅲ colorectal cancer refuse postoperative adjuvant chemotherapy ) ; The diagnosis colorectal cancer confirm pathological examination radical surgery ; The liver kidney function satisfies follow condition within 15 day surgery ( exclude day 15 ) : aspartate aminotransferase ( AST ) , glutamicoxalacetic transaminase ( ALT ) , alkaline phosphatase ( ALP ) &lt; 2 upper limit normal ( ULN ) , total bilirubin ≤ 1.5 ULN , serum creatinine &lt; 1.5 ULN ; normal coagulation function ; Other laboratory test meet following requirement within 15 day surgery ( exclude day 15 ) : white blood cell count ≥ 3.0×109/L , absolute neutrophil count ≥ 1.5×109/L , platelet count ≥ 100×109/L ; ECOG：02 points； No previous history malignancy . Multiple primary cancer ; Not recover colorectal surgery ; Presence organ , bone , skin metastasis ; Pregnant lactate woman ; Those active bleeding due various reason ; Those HIV infection AIDSassociated diseases ; Those severe acute chronic disease ; Those severe diabetes ; Those serious infectious disease ; Those take drug oral route ; Drug abuser psychological mental disease may interfere study compliance ; Conditions consider suitable study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Huaier Granule</keyword>
	<keyword>After radical surgery</keyword>
	<keyword>Prevention Recurrence Metastasis</keyword>
	<keyword>Efficacy safety</keyword>
</DOC>